---
figid: PMC4326607__nihms622554f1
figtitle: Therapeutic targets for treating fibrotic kidney diseases
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC4326607
filename: nihms622554f1.jpg
figlink: /pmc/articles/PMC4326607/figure/F1/
number: F1
caption: Initiation of the TGF-β signaling cascade occurs upon ligand binding to TβRII
  and subsequent TβRI-TβRII hetero-tetrameric complex formation. The canonical Smad
  pathway involves activation of Smad2/3 through recruitment and phosphorylation by
  activated TβRI, and requires kinase activity of TβRI. TGF-β1 also activates various
  non-Smad pathways, including TAK1 and subsequently activates several downstream
  signaling cascades, including MKK4/7–JNK, MKK3/6–p38 MAPK, and nuclear factor-kappa
  B (NF-κB)-inducing kinase-IκB kinase. TGF-β1, transforming growth factor-β1; TβRI,
  TGF-β type I receptor; TβRII, TGF-β type 2 receptor; TAK1, TGF-β-activated kinase
  1; TAB1, TAK1-binding protein 1; MKK, mitogen-activated protein kinase kinase; JNK,
  c-Jun N-terminal kinase.
papertitle: Therapeutic targets for treating fibrotic kidney diseases.
reftext: So-Young Lee, et al. Transl Res. ;165(4):512-530.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9310587
figid_alias: PMC4326607__F1
figtype: Figure
redirect_from: /figures/PMC4326607__F1
ndex: acd88751-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4326607__nihms622554f1.html
  '@type': Dataset
  description: Initiation of the TGF-β signaling cascade occurs upon ligand binding
    to TβRII and subsequent TβRI-TβRII hetero-tetrameric complex formation. The canonical
    Smad pathway involves activation of Smad2/3 through recruitment and phosphorylation
    by activated TβRI, and requires kinase activity of TβRI. TGF-β1 also activates
    various non-Smad pathways, including TAK1 and subsequently activates several downstream
    signaling cascades, including MKK4/7–JNK, MKK3/6–p38 MAPK, and nuclear factor-kappa
    B (NF-κB)-inducing kinase-IκB kinase. TGF-β1, transforming growth factor-β1; TβRI,
    TGF-β type I receptor; TβRII, TGF-β type 2 receptor; TAK1, TGF-β-activated kinase
    1; TAB1, TAK1-binding protein 1; MKK, mitogen-activated protein kinase kinase;
    JNK, c-Jun N-terminal kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tgfb1a
  - tab1
  - smad2
  - smad3a
  - smad4a
  - smad4b
  - map2k6
  - map2k4a
  - smad6a
  - smad7
  - mapk8b
  - mapk14a
  - atf2
  - TGFB1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - TGFBR1
  - TAB1
  - TGFBR2
  - MAP2K3
  - MAP2K4
  - NFKB1
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ATF2
  - GDNF
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
---
